Pharma Sustainability Integrates 2027
Value Creation, Resilience, Circularity & Supply Chain Action
- NEW 2027 DATE ANNOUNCED!
- 25th February 2027
EVENT TOPICS:
- 2027 Agenda: Value Creation, Resilience, Circularity & Supply Chain Action
Pharma has spent the last decade building evidence for sustainability. The harder question now is what to do with it. As energy costs, climate risk and regulation reshape the industry, sustainability has become a test of whether a business, supply chain or health system is built to last.
Pharma Sustainability Integrates returns for its fifth year to put the key questions to the people best placed answer them. Leaders from industry, healthcare, policy, and technology will examine how sustainability creates value, strengthens resilience, and drives action across the healthcare ecosystem.
This year we will discuss:
Building sustainability into the resilience journey, so planning for energy, water and supply shocks also prepares health systems for a changing climate.
Turning sustainability data into value creation, from impact frameworks that convince a CFO to AI that crunches carbon metrics and whether it earns its footprint.
Delivering greener products and supply chains: circularity and ecodesign across the value chain, and supplier engagement that drives real emissions reductions.
AGENDA:
08:35 - 09:35
Registration & Networking
09:35 - 09:45
09:45 - 10:15
Fireside chat
Net Zero, Net Gain? What Sustainability Is Worth When the Budget Bites
With pricing pressure, geopolitical uncertainty and reporting fatigue all biting at once, is pharma's sustainability commitment holding, or quietly slipping down the agenda? This conversation brings together senior voices from industry and healthcare to ask whether sustainability is still treated as a driver of long-term value, and what it will take to keep it there.
10:20 - 11:00
Show Me the Value: Building a Shared Case for Value Creation
The shift to more sustainable medicines manufacturing isn't starting from one place. Innovators, manufacturers, regulators, investors and health systems each face different pressures and measures of success. How can the sector build a shared understanding of value, make the case for change before complete datasets exist, and find the evidence that resonates with decision-makers across the system
11:00 – 11:30
Networking Coffee Break
PLATINUM AND HOST SPONSOR:
12:15 – 12:55
Circular by Design: Rethinking Resource Use in Pharma Manufacturing
Circularity is not only about end-of-life; some of the biggest gains can stem from using fewer resources in the first place. From process intensification and continuous manufacturing to facility design and material choices, how can pharma cut resource consumption, energy and physical footprint while maintaining or increasing output, and close the loop on what remains?
11:30 – 12:10
Making Sustainability Part of the Resilience Journey
Resilience and sustainability often run as separate programmes, yet the same shocks threaten both: energy price spikes, water scarcity, extreme weather and supplier failure. With heat-stressed hospitals and disrupted cold chains making adaptation as urgent as mitigation, this session explores how organisations fold sustainability into resilience planning, and where the two agendas reinforce each other.
12:55 - 13:55
Networking Lunch Break
GOLD AND SILVER SPONSORS:
13:55 – 14:35
Turning Supplier Engagement into Emissions Reductions
Most of pharma's footprint sits with suppliers, who are hearing the same requests from every customer. With the NHS Supplier Roadmap and pharma procurement policies setting hard expectations, how do you manage suppliers to drive action rather than data collection? This panel explores incentives, shared standards, consortium approaches and what moves the needle for smaller suppliers.
14:40 – 15:20
Smart and Sustainable? Data, AI and the Footprint of Insight
Pharma has more sustainability data than it can use, and AI promises to crunch it, turning product carbon metrics into real-time decisions. But the technology behind that promise has its own energy and water footprint. Can pharma deploy AI and automation for genuine net environmental benefit, rather than shifting impact from lab to data centre?
15.20 - 15.25
Closing Remarks
15:25 - 16:25
Networking Drinks Reception
PLATINUM AND HOST SPONSOR:
Sponsors
Partners
VENUE:
1 Embankment, London
Pharma Integrates 2026 and Pharma Sustainability Integrates 2027 Location: PwC – Embankment, London
Welcome to PwC in London
London is a diverse, interconnected hub with millions living, working and travelling throughout the city on a daily basis. This includes many of our own clients and people, and the wider business community. As the city’s population grows, challenges including affordable housing, transport and infrastructure improvements and upskilling require increased attention. We see it as our priority to help find the right solutions for London.
After almost two years of refurbishment, in 2014 we fully reopened our Embankment Place office in London, achieving the highest ever score under BREEAM, the world’s foremost environmental assessment method and rating system for buildings.
Address: Price water house Coopers LLP, 1 Embankment Place, London, WC2N 6RH
Tel: +44 (0)20 7583 5000